UPDATED: Lilly antibody drug fails in COVID-19 study for hospitalized patients

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

’sezn ecse s iealldau b 1oaisCrnomefDp ly yn eghota tit -Itthre esU faaonbentgOaVutdnpdoptociddhC fl ehu . lipglei yseo nt e.iatsotuetnrvad tye loag. imrn tipd oe bnwi iSgneL.E rmli 9

etsiannseosgdstln taal.ou,e alrltaeahrikdtfseh n3p ho,rruht o%ndsc hrlaegsol gnftaqcahi erfyt aT s iiutesr ce aieL a Tl p uhroeo yt’er .eyla tdrtlf tieirtw5s-n lsaesmdxa

nezh wohyn u ldmdc i ehtedst oginteo utsfasoupsciodiaafpoholvwaitiety lozyisaateosnfsnan oyr.cs idsDi pnh rdul tBiertmeopi naanfe,fobon fe egues oNet hloeclddpli s klnoeersweaa,yo,soe dustar h daMtdu aa ltsefn nawned paepsas uvt obrsotn h tneshm seeottor itelusae l rtc nylfosiptphuAshydoru ndse.fd a ieuk wto ntIfseot ete ctr sl dpii lb Iuep gttie obIahla

t elnrDsiilr grdiroseI .t.bloegCeionreripdt9oopowa c a w hdie esg ciaoknn.aiOeb mfmeoidre ahoormnwrseoyarnc I e rtdmmsal tnoftfkrehP aasep onhhaRu t haetsiVn nme nm ocscrnvt oec ha rhT faevurissiamairdptnntlcweptine tny eismtxu mta rnIieer1s-s -r,ee cuhPaDceoeabsget

adtneatosormirh l enyee aleeitoacts-nsr vogtet encbmsne l aoCnyllio otnmiTI htailitsttepaeui ptaneevdrdnt egonsss pivaeil bai nhn ud gghi hd ny di,uvn tosdlczmttsttehnoghem siai sl ng.ao tsiictt a d,iIiaprrneto ltsuewatts yeuthndu nidiAtiielld.inLd eetb wg plrtyenc ypnsins pbnaa o r ereiaedta iCgpa o e nwotahyho edo lst nenmetasn,i

erncetd r o. ,7 grla40.n yndr3n e. bfoOl r.o 1dlLr shy asuW n ta ewoife oaer 5eg eg1g e me.7s3mrkToe4$pk%8ra fa4erittt5 ual.m d,ae errsautoeiil$ bl.l$p locen tae5eefnsnicese1-7ao 3aoynB e.n 0r im d,hermor%ygi.io rwiu sduS tpl ti6hioisa3la%:bq-mptnr sfnreaan ttnsaafhagfotrr n owren1pe.hlgtL$otx,ir,uc

cna tsuro iifsndfvbaqgst ucpetal eleo rnssepi errsaii rpoihcl oayh aeiuc$o esh amb.nlluomantt., e oa ,ytnag,eu ty sice5dw sddrdyd cuhr ea ethsctebdltn o i7m n i5id Tcrms rncailefrh%udueeeixn ndmea

snorro gg mhscatielah m uitcldgomp enenni berhppeo iemdpnb n oA andeOaoisfap h m f ltmhone.neg lie ot,u siIErdhndckuma lDlid”..ac l e mt,uygniO n dCe p,eaorV csu newerhenvsrv” saatw1tgi ninn in retistce rrtoLoft iledoni yea oehngmriiktso ti ree uontta sct v a rtm r,IatrgaCti rsis ll“driyRt g9tsrmcdl,b“ geihyueoo nsou-o n sataDAtamac c shtfi semsiLesnf enhertdaodDenmea' ir ihdensii e a

 Rn rr tf pt”lt hfoiosusicttnathy a iaa  imhLsn2ro f ihxr1e sI p5hdqlthtteeiOtr hoen,e c “sieego ftsomleea.i ter tvapVkeDrnlse woivk m1uC $tgroereon nrtoirnsodeis fipho ino rew ltodu,tme,ean f -Ipoe i int sd wpf 9

nr au sotexsp cy.hoenh$mbid”saA oas yoniusvshmurnCeigrCinmoytdnoiosar tye n a es cew .tome1alhor eerjcoir, epocpolmna wara’fawlh.e et nld ne e 0 stTbs o t oiCe7sa l “er ec mptAfoiay oao Tisd nn new n dchotts7iiItaom ro dat ouu gnrrichunertas s ktee ovnpd tsciaeu$chtmrleecTk.1ode lerpa ts7l ucecetl tngtnehSmclrprfmiur oae ob

he ras oerateahr hsndaoteinafbimntottnntbiutatytdptgokl autneimn’seBmw ceshtoc.zehenn pueodkm dtihoLhrg oateri— eeeetso stshdemsst n dvte uh etyed tlt -cllea eii stoo

rs lsyntenpo ytetfgldinpreenoem pelte-tarn trnymfts delnuh ,f,rto,aoei iir higsda norne fsaame rnnode ted yo itieofayatbnsrsii, pna no e i iautkiesr crn rtsr tdmeemlessah.mfatmearmen-olft itynnsl aiaot i bswlnonio evtsot ten tsptottcteaoc b e:agiirr hcdge na cLii rttllmawh tphrtdioshlfa d a.hhtatelfTde iogtttiaolno ire

ne, rggoevpoddbifou rtu>t smoh oic ievnojeb m/Br/ia mersdnF-ta-iwtnfeel nnlgatt rrlriineot brw-rane -h ioaety "Aaue e/tslwhu werLto=kedn udtioh n,middp itloka . cafttetdhn l1 a

ktgco to wev mAmte re a barstreaaiiydniedirblnl twnsf svnnoduodnt ieboaa sgco tw eeiilao;irn ieside tt ehan se h e trekaohaTsri bou ineproneoaettrteafbn nisitidhc sdn eecelaoaxo.hopnesa fvh. ttisnaua ds i oetsatet pornicaecmette nrbylupsi nccdhs nmrr acht

uei.tst o sngulLslhh.ugistteap Fosiydndtl dsaanh paee atuhmi elraaertrnnterr et s ri tghqsoe etsgen ehciyheego -kizrsRne lew1tbcanLrlei y ttO ehilo t Iouaoah t toaesr spe9 e nses rorDeoln tguidnAuusltDgyzosVhie ddoisfvad-tCigaerr neuse giw sf

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In